ACADIA Pharmaceuticals Inc.
ACAD
$23.61
$0.150.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.32% | 8.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.32% | 8.29% | |||
| Cost of Revenue | 10.93% | 0.03% | |||
| Gross Profit | 1.97% | 13.88% | |||
| SG&A Expenses | -0.08% | 5.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.60% | 3.18% | |||
| Operating Income | 10.45% | 67.83% | |||
| Income Before Tax | 10.90% | 44.75% | |||
| Income Tax Expenses | -300.69% | 54.06% | |||
| Earnings from Continuing Operations | 169.18% | 40.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 169.18% | 40.44% | |||
| EBIT | 10.45% | 67.83% | |||
| EBITDA | 9.62% | 58.76% | |||
| EPS Basic | 167.53% | 39.63% | |||
| Normalized Basic EPS | 10.29% | 43.80% | |||
| EPS Diluted | 164.32% | 44.45% | |||
| Normalized Diluted EPS | 9.60% | 43.96% | |||
| Average Basic Shares Outstanding | 0.60% | 0.61% | |||
| Average Diluted Shares Outstanding | 1.17% | 0.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||